This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Search results

From Proteopedia

You searched for Fulvestrant

Jump to: navigation, search

There is no page with the exact title "Fulvestrant". The search results for "Fulvestrant" are displayed below. You can create a page titled Fulvestrant (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below 18 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Fulvestrant (42 bytes)
    1: List of pages with the keyword Fulvestrant

Page text matches

  1. 4j03 (3,645 bytes)
    2: ...of human soluble epoxide hydrolase complexed with fulvestrant==
    14: ...s was tested for inhibition of sEH. We found that fulvestrant, an anticancer agent, is a potent (KI=26nM) compe...
    16: Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.,Morisseau C, Pakhomova S, Hwang S...
  2. Category:Fulvestrant (42 bytes)
    1: List of pages with the keyword Fulvestrant
  3. 8tdu (8,166 bytes)
    16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was...
  4. 6chw (6,769 bytes)
    14: ...and ERa(Y537S) breast cancer that was superior to fulvestrant. Lastly, H3B-5942 potency can be further improved...
  5. 6p05 (4,361 bytes)
    16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
    18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen...
  6. Epoxide hydrolase 3D structures (5,584 bytes)
    70: **[[4j03]] – hSEH + fulvestrant<br />
  7. 6sbo (6,299 bytes)
    14: ...t cancer following antiestrogen therapy. However, fulvestrant shows poor pharmacokinetic properties in human, l...
  8. 6wok (6,087 bytes)
    14: ...-class" molecule with the same dual mechanisms as fulvestrant, but with significant oral exposure. Through lead...
  9. 6zoq (6,046 bytes)
    14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a...
  10. 6zor (6,025 bytes)
    14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a...
  11. 6zos (6,039 bytes)
    14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a...
  12. 7jkw (4,219 bytes)
    16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
    18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen...
  13. 7jky (4,272 bytes)
    16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
    18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen...
  14. 7jkz (4,328 bytes)
    16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
    18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen...
  15. 7te7 (6,234 bytes)
    14: ...tor degrader fulvestrant. This advance shows that fulvestrant-like genomic activities can be achieved without a...
    16: Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cance...
  16. 8tgd (8,229 bytes)
    16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was...
  17. 8xoi (1,897 bytes)
    2: ... of GPR30-Gq complex structure in the presence of fulvestrant==

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools